ITBMed AB

ITBMed AB

ITBMed AB

ITBMed is a biopharmaceutical company developing specific immunomodulatory biologics primarily for organ transplantation and stem cell transplantation.
Founded
2016
Raised
$67M
Follow us
Alexa global traffic share
Latest funding
$67,000,000
Private equity - 2018
Pablo Legorreta
Team Size
2
Employees
$67,000,000 Private equity
FinSMEs , PE HUB

ITBMed Completes up to $67M Equity Investment

Health Science